FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966354998> ?p ?o ?g. }

• W1966354998 endingPage "520" @default.
• W1966354998 startingPage "513" @default.
• W1966354998 abstract "Using fMRI, Menon and Levitin [9] clearly found for the first time that listening to music strongly modulates activity in a network of mesolimbic structures involved in reward processing including the nucleus accumbens (NAc) and the ventral tegmental area (VTA), as well as the hypothalamus, and insula, which are thought to be involved in regulating autonomic and physiological responses to rewarding and emotional stimuli. Importantly, responses in the NAc and VTA were strongly correlated pointing to an association between dopamine release and NAc response to music. Listing to pleasant music induced a strong response and significant activation of the VTA-mediated interaction of the NAc with the hypothalamus, insula, and orbitofrontal cortex. Blum et al. [10] provided the first evidence that the dopamine D2 receptor gene (DRD2) Taq 1 A1 allele significantly associated with severe alcoholism whereby the author's suggested that they found the first reward gene located in the mesolimbic system. The enhanced functional and effective connectivity between brain regions mediating reward, autonomic, and cognitive processing provides insight into understanding why listening to music is one of the most rewarding and pleasurable human experiences. However, little is known about why some people have a more or less powerful mesolimbic experience when they are listening to music. It is well-known that music may induce an endorphinergic response that is blocked by naloxone, a known opioid antagonist (Goldstein [19]). Opioid transmission in the NAc is associated with dopamine release in the VTA. Moreover, dopamine release in the VTA is linked to polymorphisms of the DRD2 gene and even attention-deficit hyperactivity disorder (ADHD), whereby carriers of the DRD2 A1 allele show a reduced NAc release of dopamine (DA). Thus it is conjectured that similar mechanisms in terms of adequate dopamine release and subsequent activation of reward circuitry by listening to music might also be affected by an individual's D2 density in the VTA mediated interaction of the NAc. It is therefore hypothesized that carriers of DRD2 A1 allele may respond significantly differently to carriers of the DRD2 A2 genotype. In this regard, carriers of the D2 A1 allele have a blunted response to glucose and monetary rewards. In contrast powerful D2 agonists like bromocryptine show a heightened activation of the reward circuitry only in DRD2 A1 allele carriers. If music causes a powerful activation in spite of the DRD2 A1 allele due to a strong DA neuronal release which subsequently impinges on existing D2 receptors, then it is reasonable to assume that music is a strong indirect D2 agonist (by virtue of DA neuronal release in the NAc) and may have important therapeutic applicability in Reward Deficiency Syndrome (RDS) related behaviors including Substance Use Disorder (SUD). Ross et al. [18] found that music therapy appears to be a novel motivational tool in a severely impaired inpatient sample of patients with co-occurring mental illness and addiction." @default.
• W1966354998 created "2016-06-24" @default.
• W1966354998 creator A5003057886 @default.
• W1966354998 creator A5017907782 @default.
• W1966354998 creator A5033241034 @default.
• W1966354998 creator A5042753204 @default.
• W1966354998 creator A5056618455 @default.
• W1966354998 creator A5063168541 @default.
• W1966354998 creator A5067927137 @default.
• W1966354998 creator A5068209735 @default.
• W1966354998 creator A5068786123 @default.
• W1966354998 creator A5077020871 @default.
• W1966354998 creator A5090335243 @default.
• W1966354998 creator A5019410149 @default.
• W1966354998 date "2010-03-01" @default.
• W1966354998 modified "2023-10-10" @default.
• W1966354998 title "Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS)" @default.
• W1966354998 cites W1507589175 @default.
• W1966354998 cites W1568198343 @default.
• W1966354998 cites W1920680810 @default.
• W1966354998 cites W1978453350 @default.
• W1966354998 cites W1982078569 @default.
• W1966354998 cites W1985021707 @default.
• W1966354998 cites W1990287391 @default.
• W1966354998 cites W1993691356 @default.
• W1966354998 cites W1994609215 @default.
• W1966354998 cites W1998674360 @default.
• W1966354998 cites W2001022907 @default.
• W1966354998 cites W2001941840 @default.
• W1966354998 cites W2005239439 @default.
• W1966354998 cites W2006627489 @default.
• W1966354998 cites W2009875407 @default.
• W1966354998 cites W2010983171 @default.
• W1966354998 cites W2013250252 @default.
• W1966354998 cites W2013645250 @default.
• W1966354998 cites W2015421768 @default.
• W1966354998 cites W2019362807 @default.
• W1966354998 cites W2019510880 @default.
• W1966354998 cites W2033640805 @default.
• W1966354998 cites W2036289590 @default.
• W1966354998 cites W2043825589 @default.
• W1966354998 cites W2044816148 @default.
• W1966354998 cites W2048611140 @default.
• W1966354998 cites W2070662532 @default.
• W1966354998 cites W2071403123 @default.
• W1966354998 cites W2078354028 @default.
• W1966354998 cites W2079427367 @default.
• W1966354998 cites W2081800734 @default.
• W1966354998 cites W2088829922 @default.
• W1966354998 cites W2092703117 @default.
• W1966354998 cites W2094579484 @default.
• W1966354998 cites W2105263730 @default.
• W1966354998 cites W2105771114 @default.
• W1966354998 cites W2115518880 @default.
• W1966354998 cites W2119128116 @default.
• W1966354998 cites W2123687826 @default.
• W1966354998 cites W2125068060 @default.
• W1966354998 cites W2127946577 @default.
• W1966354998 cites W2128323795 @default.
• W1966354998 cites W2132568992 @default.
• W1966354998 cites W2137675041 @default.
• W1966354998 cites W2137947333 @default.
• W1966354998 cites W2140467734 @default.
• W1966354998 cites W2142933456 @default.
• W1966354998 cites W2144176813 @default.
• W1966354998 cites W2146220657 @default.
• W1966354998 cites W2146843764 @default.
• W1966354998 cites W2151422895 @default.
• W1966354998 cites W2163876269 @default.
• W1966354998 cites W2164300682 @default.
• W1966354998 cites W2172155383 @default.
• W1966354998 cites W2172297693 @default.
• W1966354998 cites W4213265599 @default.
• W1966354998 doi "https://doi.org/10.1016/j.mehy.2009.10.008" @default.
• W1966354998 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19914781" @default.
• W1966354998 hasPublicationYear "2010" @default.
• W1966354998 type Work @default.
• W1966354998 sameAs 1966354998 @default.
• W1966354998 citedByCount "41" @default.
• W1966354998 countsByYear W19663549982012 @default.
• W1966354998 countsByYear W19663549982013 @default.
• W1966354998 countsByYear W19663549982014 @default.
• W1966354998 countsByYear W19663549982015 @default.
• W1966354998 countsByYear W19663549982016 @default.
• W1966354998 countsByYear W19663549982017 @default.
• W1966354998 countsByYear W19663549982018 @default.
• W1966354998 countsByYear W19663549982019 @default.
• W1966354998 countsByYear W19663549982020 @default.
• W1966354998 countsByYear W19663549982021 @default.
• W1966354998 countsByYear W19663549982022 @default.
• W1966354998 countsByYear W19663549982023 @default.
• W1966354998 crossrefType "journal-article" @default.
• W1966354998 hasAuthorship W1966354998A5003057886 @default.
• W1966354998 hasAuthorship W1966354998A5017907782 @default.
• W1966354998 hasAuthorship W1966354998A5019410149 @default.
• W1966354998 hasAuthorship W1966354998A5033241034 @default.
• W1966354998 hasAuthorship W1966354998A5042753204 @default.
• W1966354998 hasAuthorship W1966354998A5056618455 @default.

• next